One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Search from 250 M+ research papersSearch from 250 M+ research papers
Open Accesshttps://doi.org/10.1182/blood-2021-144912
Copy DOI Journal: Blood |  Publication Date: Nov 5, 2021 |
 Citations: 3 |
Affiliation: Hospices Civils de Lyon, Princess Margaret Cancer Centre, University Cancer Institute Toulouse Oncopole, Karmanos Cancer Institute, Centre Hospitalier Universitaire de Bordeaux, Forma Therapeutics (United States), Centre Hospitalier Universitaire de Nantes, Centre d'Investigation Clinique de Nantes, University of Miami, Sylvester Comprehensive Cancer Center, Sir Charles Gairdner Hospital, Government of Western Australia Department of Health, Hospital Universitari i Politècnic La Fe, Hôpital Saint-Louis, Hospital Clínic de Barcelona, Istituto di Ematologia di Bologna, National Cancer Center of Georgia, Sorbonne Université, Hôpital Saint-Antoine, Klinikum Braunschweig, Assistance Publique – Hôpitaux de Paris, Université Sorbonne Paris Nord, Hôpital Avicenne, University of Turin, Institut d'Investigació Biomédica de Bellvitge, Institut Català d'Oncologia, Institut Gustave Roussy, Royal Adelaide Hospital, Emory University, Cancer Institute (WIA), University College London, University College Hospital, University of Paris-Saclay, Institut Polytechnique de Paris, Columbia University Irving Medical Center, Royal Marsden NHS Foundation Trust, University of California, Davis, The Alfred HospitalMolecular Characteristics of Response to Olutasidenib (FT-2102) in Patients with Relapsed/Refractory mIDH1 Acute Myeloid Leukemia
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
